Dose-dependent Bioavailability

Dose-Dependent Bioavailability is a pharmacokinetic phenomenon in which the systemic exposure of a drug changes disproportionately with alterations in administered dose, distinguished from dose-independent bioavailability by its reliance on nonlinear absorption, distribution, metabolism, or excretion processes.

77

Publications

3.8K

Citations

452

Authors

153

Institutions

Publications per year

2017–2026

19

Authors

452

  1. JD
    Jürgen Drewe

    University Hospital of Basel, Switzerland

    2 publications · 88 citations

    2

    h-index

  2. KB
    Kevin Beaumont

    Pfizer (United Kingdom), United Kingdom

    1 publications · 29 citations

    1

    h-index

  3. RC
    Rajesh Chavan

    Wockhardt Hospitals, India

    1 publications · 13 citations

    1

    h-index

  4. FL
    Fangbiao Li

    Central South University, China

    1 publications · 28 citations

    1

    h-index

  5. GM
    Giovanni Merlino

    University of Udine, Italy

    1 publications · 10 citations

    1

    h-index

1–5 of 452

Venues

  1. PubMed

    Repository · 9 publications · 401 citations

    9

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 4 publications · 251 citations

    4

    h-index

  3. Clinical Pharmacokinetics

    3 publications · 156 citations

    3

    h-index

  4. Drug Metabolism and Disposition

    3 publications · 62 citations

    3

    h-index

  5. Biopharmaceutics & Drug Disposition

    2 publications · 37 citations

    2

    h-index

1–5